$Genelux (GNLX.US)$Reuters· 1 min ago Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy With Olvi-Vec in Non-Small Cell Lung Cancer
$Genelux (GNLX.US)$ Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
$Genelux (GNLX.US)$5 analysts have this as a buy. Also close to a gap up but could take a few days to reach that gap but will be worth it. $Healthy Choice Wellness (HCWC.US)$2nd day rally. Im in at 5.15. $Kairos Pharma (KAPA.US)$Also. Im in at 2.25. $Knightscope (KSCP.US)$Extremely high short interest after RS. Buying in at open with a goal of 7.75. Plan on being in the green and up 40% at the end of the day.
$Genelux (GNLX.US)$ Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates Genelux (NASDAQ: GNLX) reported its Q2 2024 financial results and provided business updates. The company completed a $30 million public offering, providing runway through three trial readouts. Genelux anticipates interim results from the Phase 2 trial in recurrent non-small cell lung cancer by mid-2025 and interim data from the Phase 1b trial in recurrent small cell...
Genelux Corporation: A Speculative Buy Worth Considering? In the volatile world of biotech investments, pinpointing potential high-reward stocks can be akin to finding a needle in a haystack. Yet, the recent analysis by Benchmark on Genelux Corporation (Ticker Symbol: GNLX) has caught the attention of many in the industry. With a reiterated speculative buy rating and a staggering price target of $30—nearly six times its current trading pri...
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Genelux Stock Forum
Genelux Achieves Breakthrough 71% Disease Control Rate in Lung Cancer Trial While Extending Cash Runway to 2026
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy With Olvi-Vec in Non-Small Cell Lung Cancer
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
$Healthy Choice Wellness (HCWC.US)$ 2nd day rally. Im in at 5.15.
$Kairos Pharma (KAPA.US)$ Also. Im in at 2.25.
$Knightscope (KSCP.US)$ Extremely high short interest after RS. Buying in at open with a goal of 7.75.
Plan on being in the green and up 40% at the end of the day.
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
Genelux (NASDAQ: GNLX) reported its Q2 2024 financial results and provided business updates. The company completed a $30 million public offering, providing runway through three trial readouts. Genelux anticipates interim results from the Phase 2 trial in recurrent non-small cell lung cancer by mid-2025 and interim data from the Phase 1b trial in recurrent small cell...
Larger Image: tradingview.com...
$Genelux (GNLX.US)$
In the volatile world of biotech investments, pinpointing potential high-reward stocks can be akin to finding a needle in a haystack. Yet, the recent analysis by Benchmark on Genelux Corporation (Ticker Symbol: GNLX) has caught the attention of many in the industry. With a reiterated speculative buy rating and a staggering price target of $30—nearly six times its current trading pri...
dropped from 35-20 in 7 days
missed my entry
No comment yet